145 related articles for article (PubMed ID: 25473892)
1. Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.
Keitel U; Scheel A; Thomale J; Halpape R; Kaulfuß S; Scheel C; Dobbelstein M
Oncotarget; 2014 Dec; 5(23):11778-91. PubMed ID: 25473892
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1.
Wang MY; Chen PS; Prakash E; Hsu HC; Huang HY; Lin MT; Chang KJ; Kuo ML
Cancer Res; 2009 Apr; 69(8):3482-91. PubMed ID: 19351859
[TBL] [Abstract][Full Text] [Related]
3. EMT-inducing transcription factor ZEB1-associated resistance to the BCL-2/BCL-X
Inoue-Yamauchi A; Oda H
Biochem Biophys Res Commun; 2020 Jun; 526(3):612-617. PubMed ID: 32247610
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
Fernández Y; España L; Mañas S; Fabra A; Sierra A
Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
[TBL] [Abstract][Full Text] [Related]
6. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy against Bcl-2-related proteins in breast cancer cells.
Emi M; Kim R; Tanabe K; Uchida Y; Toge T
Breast Cancer Res; 2005; 7(6):R940-52. PubMed ID: 16280040
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptotic Bax promotes mesenchymal-epithelial transition by binding to respiratory complex-I and antagonizing the malignant actions of pro-survival Bcl-2 proteins.
Kim EM; Jung CH; Song JY; Park JK; Um HD
Cancer Lett; 2018 Jun; 424():127-135. PubMed ID: 29596889
[TBL] [Abstract][Full Text] [Related]
9. Overcoming EMT-driven therapeutic resistance by BH3 mimetics.
Keitel U; Scheel C; Dobbelstein M
Oncoscience; 2014; 1(11):706-8. PubMed ID: 25593997
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xL promotes metastasis independent of its anti-apoptotic activity.
Choi S; Chen Z; Tang LH; Fang Y; Shin SJ; Panarelli NC; Chen YT; Li Y; Jiang X; Du YN
Nat Commun; 2016 Jan; 7():10384. PubMed ID: 26785948
[TBL] [Abstract][Full Text] [Related]
11. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
Yu X; Yang L; Cairns MJ; Dass C; Saravolac E; Li X; Sun LQ
Oncotarget; 2014 Oct; 5(19):9039-48. PubMed ID: 25344863
[TBL] [Abstract][Full Text] [Related]
13. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
14. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation.
Colié S; Van Veldhoven PP; Kedjouar B; Bedia C; Albinet V; Sorli SC; Garcia V; Djavaheri-Mergny M; Bauvy C; Codogno P; Levade T; Andrieu-Abadie N
Cancer Res; 2009 Dec; 69(24):9346-53. PubMed ID: 19934311
[TBL] [Abstract][Full Text] [Related]
15. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
16. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells.
Antonietti P; Gessler F; Düssmann H; Reimertz C; Mittelbronn M; Prehn JH; Kögel D
Biochim Biophys Acta; 2016 Apr; 1863(4):499-509. PubMed ID: 26721623
[TBL] [Abstract][Full Text] [Related]
17. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract][Full Text] [Related]
19. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
Slabáková E; Kharaishvili G; Smějová M; Pernicová Z; Suchánková T; Remšík J; Lerch S; Straková N; Bouchal J; Král M; Culig Z; Kozubík A; Souček K
Oncotarget; 2015 Nov; 6(34):36156-71. PubMed ID: 26416355
[TBL] [Abstract][Full Text] [Related]
20. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.
Ghosh-Choudhury T; Mandal CC; Woodruff K; St Clair P; Fernandes G; Choudhury GG; Ghosh-Choudhury N
Breast Cancer Res Treat; 2009 Nov; 118(1):213-28. PubMed ID: 18953692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
